About Index Trending news
Lists
Pricing
ProteoMediX

ProteoMediX

ProteoMediX

ProteoMediX is a spinoff company of ETH Zurich and specialized in theidentification of novel biomarkers for the early detection of cancer

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series C)
€4,500,000
Venture capital (Series B)
$3,345,160
Employees

Team size

2
Locations
HQ
Headquarters
€4,500,000 Venture capital (Series C)
FinSMEs

ProteoMediX Raises CHF5M in Financing Round

Health Funding